Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
POINT Biopharma Global Inc. (PNT)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
18 Dec 2023
BVF PARTNERS L P/IL
Former 10% Owner
POINT Biopharma Global Inc.
(PNT)
0
-100%
17,161,278
$12.45
$213,657,900.00
BUY
29 Nov 2022
MCCANN JOE A.
Chief Executive Officer, Director, Officer
POINT Biopharma Global Inc.
(PNT)
3,616,313
+0%
2,160
$6.64
$14,342.40
BUY
18 Nov 2022
GOODMAN JONATHAN R.
Director
POINT Biopharma Global Inc.
(PNT)
41,872
+16%
6,000
$6.33
$37,980.00
BUY
17 Nov 2022
SILBER ALLAN C
Executive Chairman, Director, Officer, 10% Owner
POINT Biopharma Global Inc.
(PNT)
4,268,605
+1%
50,000
$6.22
$311,198.50
SELL
25 May 2022
FLESHNER NEIL E.
Chief Medical Officer, Director, Officer
POINT Biopharma Global Inc.
(PNT)
3,023,045
-15%
564,204
$7.51
$4,237,172.00
BUY
29 Jun 2021
RA CAPITAL MANAGEMENT, L.P.
Director
Therapeutics Acquisition Corp.
(RACA)
1,098,318
+23%
209,100
$10.00
$2,091,000.00
Home